Applications of liquid biopsies as prognostic markers in patients (pts) with advanced ovarian cancer (AOC) on metronomic cyclophosphamide (MCy) with or without nintedanib (N) (Trans METRO-BIBF).

Download PDF

By | August 28th, 2018|Scientific posters|0 Comments

Beck J et al. Cell-free DNA for treatment monitoring and outcome predictor in head and neck cancer. J Clin Oncol (2017): suppl. 6055

Download PDF

By | August 28th, 2018|Scientific posters|0 Comments

Weiss GJ et al. Tumor cell-free DNA copy number instability (CNI) to predict therapeutic response to immunotherapy prior to cycle 2. J Clin Oncol (2016): suppl; a3027

Download PDF

By | August 28th, 2018|Scientific posters|0 Comments

Kundranda MN et al. Genomic change index (GCI) and liquid biopsies in predicting and monitoring response to therapy in advanced pancreatic ductal adenocarcinoma (PDAC). J Clin Oncol (2015): suppl 3; a309

Download PDF

By | August 28th, 2018|Scientific posters|0 Comments

Urnovitz HB et al. Detection of novel HPV mutations and chromosomal number imbalance (CNI) in laryngeal cancer using next-generation sequencing (NGS). J Clin Oncol (2014): suppl; a6072

Download PDF

By | August 28th, 2018|Scientific posters|0 Comments

Beck J et al. Cell-free DNA copy number variations as a marker for breast cancer in a large study cohort. J Clin Oncol (2013): suppl; a11013

Download PDF

By | August 28th, 2018|Scientific posters|0 Comments

Urnovitz HB et al. Modulation of breast cancer cell-free DNA with surgical resection. J Clin Oncol (2013): suppl; a11060

Download PDF

By | August 28th, 2018|Scientific posters|0 Comments

Schütz E et al. Quantifying copy number variations in cell-free DNA for potential clinical utility from a large prostate cancer cohort. J Clin Oncol (2013): suppl; a5072

Download PDF

By | August 28th, 2018|Scientific posters|0 Comments